---
schema_version: "secwatch.filing_event.v1"
accession: "0001600620-23-000027"
form_type: "8-K"
ticker: "AUPH"
cik: "0001600620"
company_name: "Aurinia Pharmaceuticals Inc."
filed_at: "2023-07-03T23:59:59+00:00"
generated_at: "2026-06-13T13:17:03.549930+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aurinia board explores strategic alternatives including sale; two directors resign after vote shortfall

## Summary
- Board initiated exploration of strategic alternatives including sale, merger, or other transaction.
- Retained JP Morgan as financial advisor; Skadden Arps and Borden Ladner Gervais as legal counsel.
- Directors George Milne and Joseph Hagan resigned effective June 29 after less-than-majority support at AGM.
- Korn Ferry engaged to search for two new board members.
- No timetable set; no assurance of any transaction outcome.

## SEC filing metadata
- accession: 0001600620-23-000027
- form_type: 8-K
- ticker: AUPH
- cik: 0001600620
- company_name: Aurinia Pharmaceuticals Inc.
- filed_at: 2023-07-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1600620/000160062023000027/0001600620-23-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1600620/000160062023000027/auph-20230629.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001600620-23-000027
- JSON: https://secwatch.observer/filing/0001600620-23-000027.json
- Plain text: https://secwatch.observer/filing/0001600620-23-000027.txt

## Key facts
- Executive change
  George Milne resigned as director at Aurinia Pharmaceuticals Inc..
  - Action: resigned
  - Role: director
  source text: the Board, following the deliberation process outlined in the Company’s Majority Voting Policy, determined to accept the resignations of Dr. Milne and Mr. Hagan effective June 29, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1600620/000160062023000027/0001600620-23-000027-index.htm
- Executive change
  Joseph P. Hagan resigned as director at Aurinia Pharmaceuticals Inc..
  - Action: resigned
  - Role: director
  source text: the Board, following the deliberation process outlined in the Company’s Majority Voting Policy, determined to accept the resignations of Dr. Milne and Mr. Hagan effective June 29, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1600620/000160062023000027/0001600620-23-000027-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.